“The reason for Cardiocom’s success in the emerging home tele-monitoring market is clear – quality products and services,” says Frost & Sullivan Research Analyst Zachary Bujnoch. “Many health agencies and hospitals feel that their older systems have not lived up to expectations, and as buyers begin to exercise more choices in their remote patient monitoring purchasing decisions, cutting-edge systems such as Cardiocom look better by comparison.”
The way Cardiocom has positioned itself plays a critical part in differentiating it from competitors. Most companies in the home health monitoring and disease management markets reach outside of their core expertise for many of their needs, ranging from the acquisition of new technology to the full outsourcing of manufacturing devices and other major components. Cardiocom strives for the exact opposite.
Cardiocom’s founders have leveraged their strong experience in medical device manufacturing to create a home monitoring company that designs, manufactures, and supports all of its products internally.
To achieve this, Cardiocom has its own in-house research and development team and manufacturing operations, along with a full call-center staffed by registered nurses. This initiative for vertical integration by Cardiocom has truly set this company apart from its competitors and has been key to its success.
Cardiocom’s solutions are more than just biometric monitoring devices. The products and services operate as an integrated system for specific disease states. By incorporating state-of-the-art monitoring technology with targeted, personalized care management services and advanced rule-based software, Cardiocom offers its clients maximum patient management.
Many of Cardiocom’s systems directly address a specific disease state, but more customizable monitoring options are also available for specific conditions. The two largest disease management services offered by Cardiocom are focused on cardiac conditions and diabetes, respectively. Other diseases that have dedicated systems include hypertension, end-stage renal failure, high-risk obesity, COPD, asthma, and obesity management.
Although the systems themselves are the true innovative “products” that this Frost & Sullivan Award addresses, it is worth noting that “many of the actual monitoring devices embedded in these systems were designed and developed by Cardiocom in-house.” notes Zachary Bujnoch. In addition, many components are patented for use only in Cardiocom's systems, such as clinical branching logic and two-way patient messaging systems.
While other home telemonitoring and disease management companies were struggling to stay profitable or just stay in business, Cardiocom has maintained profitability for the past six years and is expected to continue on that path in the years to come.
In recognition of these achievements, Frost & Sullivan is proud to present Cardiocom with the 2008 Patient Monitoring Product Innovation of the Year Award.
Each year, Frost & Sullivan presents this Award to the company that has demonstrated the ability to develop and/or advance products with more innovative capabilities than competing vendors and products. The Award recognizes the company’s successful adoption of new or existing technology that has become a part of its well-designed product family. Such innovation is expected to significantly contribute to the industry in terms of product performance and degree/rate of technical change.
Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.
About Cardiocom LLC
Cardiocom (cardiocom.com) is a leader in innovative patient telemonitoring and disease management solutions. Founded in 1997, Cardiocom develops, manufactures and markets its own telehealth devices for congestive heart failure, diabetes, hypertension, obesity, COPD, severe asthma, and ESRD. The Company also has a specialized diabetes care division, GlucoCom™ (glucocom.com), that provides blood glucose monitoring products. Cardiocom’s clients include some of the most respected health plans, hospitals, physician groups, home health groups and disease management vendors in the nation. Through these established relationships, Cardiocom improves the lives of thousands of people each day. Contact Jodie Root P: (888) 243-8881 E: jroot[.]cardiocom.com.
About Frost & Sullivan
Frost & Sullivan, the Global Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.